Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Monday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Stock Performance

NASDAQ:AEMD opened at $0.41 on Monday. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35. The stock has a market cap of $5.75 million, a PE ratio of -0.15 and a beta of 1.74. The stock has a 50 day moving average price of $0.40 and a 200 day moving average price of $0.42.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.